Ondansetron Plus Dexamethasone With or Without Metoclopramide as Antiemetic Prophylaxis After Receiving Cisplatin
The objective of this study is to assess the efficacy and tolerability of metoclopramide added to standard antiemetic regimen for prophylaxis of cisplatin-induced emesis.
Cancer
DRUG: metoclopramide|DRUG: placebo
Number of Patients Who Had Complete Response, number of patients who experience no emesis and need no rescue treatment in 5-day period, 5 days after receiving chemotherapy
Toxicities and Severity of Nausea and Vomiting, 5 days after receiving chemotherapy
Ondansetron plus dexamethasone are standard emetic prophylactic agents for highly emetogenic chemotherapy. Metoclopramide is a dopamine antagonist, which may enhance efficacy of ondansetron and dexamethasone.